Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nathan Katz, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Farrar JT, Bilker WB, Cochetti PT, Argoff CE, Haythornthwaite J, Katz NP, Gilron I. Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data. Pain. 2022 Jan 01; 163(1):47-57. PMID: 34261978; PMCID: PMC8675053.
    Citations:    Fields:    Translation:Humans
  2. Ross E, Katz NP, Conaghan PG, Kivitz A, Turk DC, Spitzer AI, Jones DG, Lanier RK, Cinar A, Lufkin J, Kelley SD. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales. Pain Ther. 2022 Mar; 11(1):289-302. PMID: 34791634; PMCID: PMC8861226.
    Citations:    
  3. Gewandter JS, Smith SM, Dworkin RH, Turk DC, Gan TJ, Gilron I, Hertz S, Katz NP, Markman JD, Raja SN, Rowbotham MC, Stacey BR, Strain EC, Ward DS, Farrar JT, Kroenke K, Rathmell JP, Rauck R, Brown C, Cowan P, Edwards RR, Eisenach JC, Ferguson M, Freeman R, Gray R, Giblin K, Grol-Prokopczyk H, Haythornthwaite J, Jamison RN, Martel M, McNicol E, L Oshinsky M, Sandbrink F, Scholz J, Scranton R, Simon LS, Steiner D, Verburg K, Wasan AD, Wentworth K. Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations. Pain. 2021 11 01; 162(11):2669-2681. PMID: 33863862; PMCID: PMC8497633.
    Citations: 2     Fields:    Translation:Humans
  4. Kleykamp BA, Dworkin RH, Turk DC, Bhagwagar Z, Cowan P, Eccleston C, Ellenberg SS, Evans SR, Farrar JT, Freeman RL, Garrison LP, Gewandter JS, Goli V, Iyengar S, Jadad AR, Jensen MP, Junor R, Katz NP, Kesslak JP, Kopecky EA, Lissin D, Markman JD, McDermott MP, Mease PJ, O'Connor AB, Patel KV, Raja SN, Rowbotham MC, Sampaio C, Singh JA, Steigerwald I, Strand V, Tive LA, Tobias J, Wasan AD, Wilson HD. Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2022 06 01; 163(6):1006-1018. PMID: 34510135; PMCID: PMC8904641.
    Citations:    Fields:    Translation:Humans
  5. Evans K, Colloca L, Pecina M, Katz N. What can be done to control the placebo response in clinical trials? A narrative review. Contemp Clin Trials. 2021 08; 107:106503. PMID: 34237458; PMCID: PMC8719632.
    Citations: 1     Fields:    Translation:Humans
  6. Katz N, Dworkin RH, North R, Thomson S, Eldabe S, Hayek SM, Kopell BH, Markman J, Rezai A, Taylor RS, Turk DC, Buchser E, Fields H, Fiore G, Ferguson M, Gewandter J, Hilker C, Jain R, Leitner A, Loeser J, McNicol E, Nurmikko T, Shipley J, Singh R, Trescot A, van Dongen R, Venkatesan L. Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations. Pain. 2021 07 01; 162(7):1935-1956. PMID: 33470748; PMCID: PMC8208090.
    Citations: 6     Fields:    Translation:Humans
  7. Gewandter JS, McDermott MP, Evans S, Katz NP, Markman JD, Simon LS, Turk DC, Dworkin RH. Composite outcomes for pain clinical trials: considerations for design and interpretation. Pain. 2021 07 01; 162(7):1899-1905. PMID: 33449513; PMCID: PMC8991304.
    Citations: 8     Fields:    Translation:Humans
  8. Park J, Lucas AM, Zhang X, Chaudhary K, Cho JH, Nadkarni G, Dobbyn A, Chittoor G, Josyula NS, Katz N, Breeyear JH, Ahmadmehrabi S, Drivas TG, Chavali VRM, Fasolino M, Sawada H, Daugherty A, Li Y, Zhang C, Bradford Y, Weaver J, Verma A, Judy RL, Kember RL, Overton JD, Reid JG, Ferreira MAR, Li AH, Baras A, LeMaire SA, Shen YH, Naji A, Kaestner KH, Vahedi G, Edwards TL, Chen J, Damrauer SM, Justice AE, Do R, Ritchie MD, Rader DJ. Exome-wide evaluation of rare coding variants using electronic health records identifies new gene-phenotype associations. Nat Med. 2021 01; 27(1):66-72. PMID: 33432171; PMCID: PMC8775355.
    Citations: 18     Fields:    Translation:Humans
  9. Alexander RC, Raudibaugh K, Spierings ELH, Katz N. A 3-way Cross-over Study of Pregabalin, Placebo, and the Histamine 3 Receptor Inverse Agonist AZD5213 in Combination With Pregabalin in Patients With Painful Diabetic Neuropathy and Good Pain-reporting Ability. Clin J Pain. 2021 01; 37(1):38-42. PMID: 33086238.
    Citations: 2     Fields:    Translation:Humans
  10. Erpelding N, Evans K, Lanier RK, Elder H, Katz NP. Placebo Response Reduction and Accurate Pain Reporting Training Reduces Placebo Responses in a Clinical Trial on Chronic Low Back Pain: Results From a Comparison to the Literature. Clin J Pain. 2020 12; 36(12):950-954. PMID: 32841968.
    Citations: 4     Fields:    Translation:Humans
  11. Gudin J, Rauck R, Argoff C, Agaiby E, Gimbel J, Katz N, Doberstein SK, Tagliaferri M, Tagliaferri M, Potts J, Wild J, Lu L, Siddhanti S, Hale M, Markman J. Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS). Pain Med. 2020 11 07; 21(7):1347-1356. PMID: 31361019; PMCID: PMC7372935.
    Citations: 3     Fields:    Translation:Humans
  12. Smith SM, Dworkin RH, Turk DC, McDermott MP, Eccleston C, Farrar JT, Rowbotham MC, Bhagwagar Z, Burke LB, Cowan P, Ellenberg SS, Evans SR, Freeman RL, Garrison LP, Iyengar S, Jadad A, Jensen MP, Junor R, Kamp C, Katz NP, Kesslak JP, Kopecky EA, Lissin D, Markman JD, Mease PJ, O'Connor AB, Patel KV, Raja SN, Sampaio C, Schoenfeld D, Singh J, Steigerwald I, Strand V, Tive LA, Tobias J, Wasan AD, Wilson HD. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain. 2020 11; 161(11):2446-2461. PMID: 32520773.
    Citations: 12     Fields:    Translation:Humans
  13. White AG, Birnbaum HG, Mareva MN, Daher M, Vallow S, Schein J, Katz N. Direct Costs of Opioid Abuse in an Insured Population in the United States. J Manag Care Spec Pharm. 2020 Oct; 26(10):1188-1198. PMID: 32996392.
    Citations:    Fields:    Translation:Humans
  14. Evans K, Romero H, Spierings EL, Katz N. The relation between the placebo response, observed treatment effect, and failure to meet primary endpoint: A systematic review of clinical trials of preventative pharmacological migraine treatments. Cephalalgia. 2021 02; 41(2):247-255. PMID: 32960658.
    Citations: 1     Fields:    Translation:Humans
  15. Henningfield JE, Gudin J, Rauck R, Gimbel J, Tagliaferri M, Doberstein SK, Di Fonzo C, Lu L, Katz N, Siddhanti S, Schnoll S. Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain. Pain Med. 2020 08 01; 21(8):1553-1561. PMID: 32150255; PMCID: PMC7530570.
    Citations: 2     Fields:    Translation:HumansAnimalsCTClinical Trials
  16. McNicol E, Ferguson M, Bungay K, Rowe EL, Eldabe S, Gewandter JS, Hayek SM, Katz N, Kopell BH, Markman J, Rezai A, Taylor RS, Turk DC, Dworkin RH, North RB, Thomson S. Systematic Review of Research Methods and Reporting Quality of Randomized Clinical Trials of Spinal Cord Stimulation for Pain. J Pain. 2021 02; 22(2):127-142. PMID: 32574787.
    Citations: 4     Fields:    Translation:Humans
  17. As-Sanie S, Soliman AM, Evans K, Erpelding N, Lanier RK, Katz NP. Short-acting and Long-acting Opioids Utilization among Women Diagnosed with Endometriosis in the United States: A Population-based Claims Study. J Minim Invasive Gynecol. 2021 02; 28(2):297-306.e2. PMID: 32531340.
    Citations: 4     Fields:    Translation:Humans
  18. Gandhi K, Wei W, Huang A, Wang L, Iyer R, Katz NP. A Real-World Study Using Claims Data to Evaluate Possible Failure of Opioid Treatment Regimens Among Patients with Hip and/or Knee Osteoarthritis in the US. Clinicoecon Outcomes Res. 2020; 12:285-297. PMID: 32606845; PMCID: PMC7293383.
    Citations: 2     
  19. Hinderer C, Katz N, Dyer C, Goode T, Johansson J, Bell P, Richman L, Buza E, Wilson JM. Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration. Mol Ther Methods Clin Dev. 2020 Jun 12; 17:969-974. PMID: 32420410; PMCID: PMC7218226.
    Citations: 10     
  20. Gewandter JS, Dworkin RH, Turk DC, Devine EG, Hewitt D, Jensen MP, Katz NP, Kirkwood AA, Malamut R, Markman JD, Vrijens B, Burke L, Campbell JN, Carr DB, Conaghan PG, Cowan P, Doyle MK, Edwards RR, Evans SR, Farrar JT, Freeman R, Gilron I, Juge D, Kerns RD, Kopecky EA, McDermott MP, Niebler G, Patel KV, Rauck R, Rice ASC, Rowbotham M, Sessler NE, Simon LS, Singla N, Skljarevski V, Tockarshewsky T, Vanhove GF, Wasan AD, Witter J. Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations. J Pain. 2020 Sep - Oct; 21(9-10):931-942. PMID: 31843583.
    Citations: 17     Fields:    Translation:Humans
  21. Meske DS, Vaughn BJ, Kopecky EA, Katz N. Number Of Clinical Trial Study Sites Impacts Observed Treatment Effect Size: An Analysis Of Randomized Controlled Trials Of Opioids For Chronic Pain. J Pain Res. 2019; 12:3161-3165. PMID: 31819600; PMCID: PMC6875508.
    Citations: 3     
  22. Treister R, Honigman L, Lawal OD, Lanier RK, Katz NP. A deeper look at pain variability and its relationship with the placebo response: results from a randomized, double-blind, placebo-controlled clinical trial of naproxen in osteoarthritis of the knee. Pain. 2019 07; 160(7):1522-1528. PMID: 30817436.
    Citations: 13     Fields:    Translation:Humans
  23. Gewandter JS, McDermott MP, Mbowe O, Edwards RR, Katz NP, Turk DC, Dworkin RH. Navigating trials of personalized pain treatments: we're going to need a bigger boat. Pain. 2019 06; 160(6):1235-1239. PMID: 30694930; PMCID: PMC6784313.
    Citations: 6     Fields:    Translation:Humans
  24. Markman J, Gudin J, Rauck R, Argoff C, Rowbotham M, Agaiby E, Gimbel J, Katz N, Doberstein SK, Tagliaferri M, Lu L, Siddhanti S, Hale M. SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain. Pain. 2019 06; 160(6):1374-1382. PMID: 30747908; PMCID: PMC6553961.
    Citations: 8     Fields:    Translation:Humans
  25. Lanier RK, Henningfield JE, Gudin J, Rauck R, Elder H, Erpelding N, Treister R, Gimbel J, Tagliaferri M, Doberstein SK, Di Fonzo CJ, Lu L, Siddhanti S, Katz NP. Assessment of potentially abuse-related events in two phase 3 studies of NKTR-181, a novel opioid analgesic, using the MADDERS® system (Misuse, Abuse, and Diversion Drug Event Reporting System). Curr Med Res Opin. 2019 09; 35(9):1513-1522. PMID: 30932719.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  26. Gewandter JS, McDermott MP, He H, Gao S, Cai X, Farrar JT, Katz NP, Markman JD, Senn S, Turk DC, Dworkin RH. Demonstrating Heterogeneity of Treatment Effects Among Patients: An Overlooked but Important Step Toward Precision Medicine. Clin Pharmacol Ther. 2019 07; 106(1):204-210. PMID: 30661240; PMCID: PMC6784315.
    Citations: 7     Fields:    Translation:Humans
  27. Treister R, Suzan E, Lawal OD, Katz NP. Staircase-evoked Pain May be More Sensitive Than Traditional Pain Assessments in Discriminating Analgesic Effects: A Randomized, Placebo-controlled Trial of Naproxen in Patients With Osteoarthritis of the Knee. Clin J Pain. 2019 01; 35(1):50-55. PMID: 30222614.
    Citations: 3     Fields:    Translation:Humans
  28. Patel KV, Allen R, Burke L, Farrar JT, Gewandter JS, Gilron I, Katz NP, Markman JD, Marshall SF, Resnick M, Rice ASC, Rowbotham MC, Smith SM, Vanhove GF, Wasan AD, Zhang S, Dworkin RH, Turk DC. Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis. Pain. 2018 Nov; 159(11):2245-2254. PMID: 30001225; PMCID: PMC7184787.
    Citations: 12     Fields:    Translation:Humans
  29. Arsenault P, Chiche D, Brown W, Miller J, Treister R, Leff R, Walker P, Katz N. NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain. Pain Rep. 2018 Nov; 3(6):e696. PMID: 30706039; PMCID: PMC6344137.
    Citations: 17     
  30. Markman J, Resnick M, Greenberg S, Katz N, Yang R, Scavone J, Whalen E, Gregorian G, Parsons B, Knapp L. Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial. J Neurol. 2018 Dec; 265(12):2815-2824. PMID: 30242745; PMCID: PMC6244661.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  31. Gewandter JS, Brell J, Cavaletti G, Dougherty PM, Evans S, Howie L, McDermott MP, O'Mara A, Smith AG, Dastros-Pitei D, Gauthier LR, Haroutounian S, Jarpe M, Katz NP, Loprinzi C, Richardson P, Lavoie-Smith EM, Wen PY, Turk DC, Dworkin RH, Freeman R. Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations. Neurology. 2018 08 28; 91(9):403-413. PMID: 30054438.
    Citations: 19     Fields:    Translation:Humans
  32. Hordeaux J, Hinderer C, Goode T, Katz N, Buza EL, Bell P, Calcedo R, Richman LK, Wilson JM. Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques. Mol Ther Methods Clin Dev. 2018 Sep 21; 10:79-88. PMID: 30073179; PMCID: PMC6070681.
    Citations: 41     
  33. Treister R, Lawal OD, Shecter JD, Khurana N, Bothmer J, Field M, Harte SE, Kruger GH, Katz NP. Accurate pain reporting training diminishes the placebo response: Results from a randomised, double-blind, crossover trial. PLoS One. 2018; 13(5):e0197844. PMID: 29795665; PMCID: PMC5993117.
    Citations: 22     Fields:    Translation:Humans
  34. Meske DS, Lawal OD, Elder H, Langberg V, Paillard F, Katz N. Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials. J Pain Res. 2018; 11:923-934. PMID: 29765246; PMCID: PMC5939920.
    Citations: 27     
  35. Mohanty M, Lawal OD, Skeer M, Lanier R, Erpelding N, Katz N. Medication errors involving intravenous patient-controlled analgesia: results from the 2005-2015 MEDMARX database. Ther Adv Drug Saf. 2018 Aug; 9(8):389-404. PMID: 30364852; PMCID: PMC6199682.
    Citations: 6     
  36. Conaghan PG, Hunter DJ, Cohen SB, Kraus VB, Berenbaum F, Lieberman JR, Jones DG, Spitzer AI, Jevsevar DS, Katz NP, Burgess DJ, Lufkin J, Johnson JR, Bodick N. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study. J Bone Joint Surg Am. 2018 Apr 18; 100(8):666-677. PMID: 29664853; PMCID: PMC5916484.
    Citations: 46     Fields:    Translation:HumansCTClinical Trials
  37. Lawal OD, Mohanty M, Elder H, Skeer M, Erpelding N, Lanier R, Katz N. The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database. Expert Opin Drug Saf. 2018 Apr; 17(4):347-357. PMID: 29463158.
    Citations: 4     Fields:    Translation:Humans
  38. Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM. The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice. Mol Ther. 2018 03 07; 26(3):664-668. PMID: 29428298; PMCID: PMC5911151.
    Citations: 156     Fields:    Translation:AnimalsCells
  39. Miller CJ, Dart RC, Katz NP, Webster LR. Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids. J Opioid Manag. 2017 Nov/Dec; 13(6):379-389. PMID: 29308585.
    Citations:    Fields:    Translation:Humans
  40. Hinderer C, Katz N, Louboutin JP, Bell P, Tolar J, Orchard PJ, Lund TC, Nayal M, Weng L, Mesaros C, de Souza CFM, Dalla Corte A, Giugliani R, Wilson JM. Abnormal polyamine metabolism is unique to the neuropathic forms of MPS: potential for biomarker development and insight into pathogenesis. Hum Mol Genet. 2017 10 01; 26(19):3837-3849. PMID: 28934395; PMCID: PMC5886077.
    Citations: 1     Fields:    Translation:HumansAnimals
  41. Backonja M, Williams L, Miao X, Katz N, Chen C. Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial). Pain. 2017 Sep; 158(9):1802-1812. PMID: 28746076; PMCID: PMC5761750.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  42. Mayorga AJ, Flores CM, Trudeau JJ, Moyer JA, Shalayda K, Dale M, Frustaci ME, Katz N, Manitpisitkul P, Treister R, Ratcliffe S, Romano G. A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis. Scand J Pain. 2017 10; 17:134-143. PMID: 28850367.
    Citations: 14     Fields:    Translation:Humans
  43. Landsman-Blumberg PB, Katz N, Gajria K, D'Souza AO, Chaudhari SL, Yeung PP, White R. Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients. J Pain Res. 2017; 10:1713-1722. PMID: 28769587; PMCID: PMC5533567.
    Citations: 3     
  44. Landsman-Blumberg PB, Katz N, Gajria K, Coutinho AD, Yeung PP, White R. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain. J Manag Care Spec Pharm. 2017 Jul; 23(7):718-724. PMID: 28650247.
    Citations: 7     Fields:    Translation:Humans
  45. Schickel JN, Glauzy S, Ng YS, Chamberlain N, Massad C, Isnardi I, Katz N, Uzel G, Holland SM, Picard C, Puel A, Casanova JL, Meffre E. Self-reactive VH4-34-expressing IgG B cells recognize commensal bacteria. J Exp Med. 2017 Jul 03; 214(7):1991-2003. PMID: 28500047; PMCID: PMC5502416.
    Citations: 32     Fields:    Translation:HumansCells
  46. Smith SM, Jones JK, Katz NP, Roland CL, Setnik B, Trudeau JJ, Wright S, Burke LB, Comer SD, Dart RC, Dionne R, Haddox JD, Jaffe JH, Kopecky EA, Martell BA, Montoya ID, Stanton M, Wasan AD, Turk DC, Dworkin RH. Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations. J Pain. 2017 11; 18(11):1287-1294. PMID: 28479207; PMCID: PMC5660635.
    Citations: 2     Fields:    Translation:Humans
  47. Sanga P, Katz N, Polverejan E, Wang S, Kelly KM, Haeussler J, Thipphawong J. Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study. Arthritis Rheumatol. 2017 04; 69(4):763-773. PMID: 27748055.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  48. Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, Borsook D, Edwards RR, Harris RE, Wager TD, Arendt-Nielsen L, Burke LB, Carr DB, Chappell A, Farrar JT, Freeman R, Gilron I, Goli V, Haeussler J, Jensen T, Katz NP, Kent J, Kopecky EA, Lee DA, Maixner W, Markman JD, McArthur JC, McDermott MP, Parvathenani L, Raja SN, Rappaport BA, Rice ASC, Rowbotham MC, Tobias JK, Wasan AD, Witter J. The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations. J Pain. 2017 07; 18(7):757-777. PMID: 28254585; PMCID: PMC5484729.
    Citations: 45     Fields:    Translation:Humans
  49. Treister R, Eaton TA, Trudeau JJ, Elder H, Katz NP. Development and preliminary validation of the focused analgesia selection test to identify accurate pain reporters. J Pain Res. 2017; 10:319-326. PMID: 28243138; PMCID: PMC5315353.
    Citations: 9     
  50. Katz NP, Gajria KL, Shillington AC, Stephenson JJ, Harshaw Q. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study. Postgrad Med. 2017 Jan; 129(1):32-39. PMID: 27846789.
    Citations: 3     Fields:    Translation:Humans
  51. Treister R, Trudeau JJ, Van Inwegen R, Jones JK, Katz NP. Development and feasibility of the misuse, abuse, and diversion drug event reporting system (MADDERS®). Am J Addict. 2016 12; 25(8):641-651. PMID: 28051840.
    Citations: 6     Fields:    Translation:Humans
  52. Gimbel J, Spierings ELH, Katz N, Xiang Q, Tzanis E, Finn A. Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study. Pain. 2016 11; 157(11):2517-2526. PMID: 27434505; PMCID: PMC5065057.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  53. Gewandter JS, McDermott MP, McKeown A, Hoang K, Iwan K, Kralovic S, Rothstein D, Gilron I, Katz NP, Raja SN, Senn S, Smith SM, Turk DC, Dworkin RH. Reporting of cross-over clinical trials of analgesic treatments for chronic pain: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review and recommendations. Pain. 2016 11; 157(11):2544-2551. PMID: 27437786.
    Citations: 8     Fields:    Translation:HumansAnimals
  54. Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B, Katz N. Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. J Pain. 2017 01; 18(1):42-53. PMID: 27746370.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  55. Edwards RR, Dworkin RH, Turk DC, Angst MS, Dionne R, Freeman R, Hansson P, Haroutounian S, Arendt-Nielsen L, Attal N, Baron R, Brell J, Bujanover S, Burke LB, Carr D, Chappell AS, Cowan P, Etropolski M, Fillingim RB, Gewandter JS, Katz NP, Kopecky EA, Markman JD, Nomikos G, Porter L, Rappaport BA, Rice ASC, Scavone JM, Scholz J, Simon LS, Smith SM, Tobias J, Tockarshewsky T, Veasley C, Versavel M, Wasan AD, Wen W, Yarnitsky D. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2016 Sep; 157(9):1851-1871. PMID: 27152687; PMCID: PMC5965275.
    Citations: 100     Fields:    Translation:Humans
  56. Williams MR, McKeown A, Pressman Z, Hunsinger M, Lee K, Coplan P, Gilron I, Katz NP, McDermott MP, Raja SN, Rappaport BA, Rowbotham MC, Turk DC, Dworkin RH, Smith SM. Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review. J Pain. 2016 11; 17(11):1137-1149. PMID: 27522950.
    Citations: 5     Fields:    Translation:Humans
  57. Schickel JN, Kuhny M, Baldo A, Bannock JM, Massad C, Wang H, Katz N, Oe T, Menard L, Soulas-Sprauel P, Strowig T, Flavell R, Meffre E. PTPN22 inhibition resets defective human central B cell tolerance. Sci Immunol. 2016; 1(1). PMID: 27917411; PMCID: PMC5127630.
    Citations: 33     Fields:    
  58. Hinderer C, Bell P, Louboutin JP, Katz N, Zhu Y, Lin G, Choa R, Bagel J, O'Donnell P, Fitzgerald CA, Langan T, Wang P, Casal ML, Haskins ME, Wilson JM. Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model. Mol Genet Metab. 2016 09; 119(1-2):124-30. PMID: 27386755; PMCID: PMC5240037.
    Citations: 20     Fields:    Translation:HumansAnimals
  59. Cooper SA, Desjardins PJ, Turk DC, Dworkin RH, Katz NP, Kehlet H, Ballantyne JC, Burke LB, Carragee E, Cowan P, Croll S, Dionne RA, Farrar JT, Gilron I, Gordon DB, Iyengar S, Jay GW, Kalso EA, Kerns RD, McDermott MP, Raja SN, Rappaport BA, Rauschkolb C, Royal MA, Segerdahl M, Stauffer JW, Todd KH, Vanhove GF, Wallace MS, West C, White RE, Wu C. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain. 2016 Feb; 157(2):288-301. PMID: 26683233.
    Citations: 29     Fields:    Translation:Humans
  60. Katz N, Kopecky EA, O'Connor M, Brown RH, Fleming AB. A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain. Pain. 2015 Dec; 156(12):2458-2467. PMID: 26262828.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  61. Katz NP, Mou J, Paillard FC, Turnbull B, Trudeau J, Stoker M. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza). Clin J Pain. 2015 Oct; 31(10):859-66. PMID: 25503598.
    Citations: 14     Fields:    Translation:Humans
  62. Sopata M, Katz N, Carey W, Smith MD, Keller D, Verburg KM, West CR, Wolfram G, Brown MT. Efficacy and safety of tanezumab in the treatment of pain from bone metastases. Pain. 2015 Sep; 156(9):1703-1713. PMID: 25919474.
    Citations: 29     Fields:    Translation:Humans
  63. Moore RA, Wiffen PJ, Eccleston C, Derry S, Baron R, Bell RF, Furlan AD, Gilron I, Haroutounian S, Katz NP, Lipman AG, Morley S, Peloso PM, Quessy SN, Seers K, Strassels SA, Straube S. Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting. Pain. 2015 Aug; 156(8):1382-1395. PMID: 25985142.
    Citations: 33     Fields:    Translation:Humans
  64. Turk DC, Dworkin RH, Trudeau JJ, Benson C, Biondi DM, Katz NP, Kim M. Validation of the Hospital Anxiety and Depression Scale in Patients With Acute Low Back Pain. J Pain. 2015 Oct; 16(10):1012-21. PMID: 26208762.
    Citations: 26     Fields:    Translation:Humans
  65. Katz NP, Mou J, Trudeau J, Xiang J, Vorsanger G, Orman C, Kim M. Development and preliminary validation of an integrated efficacy-tolerability composite measure for the evaluation of analgesics. Pain. 2015 Jul; 156(7):1357-1365. PMID: 25867124.
    Citations: 4     Fields:    Translation:Humans
  66. Katz N. Model-based drug development: the case of delayed-onset muscle soreness. Pain. 2015 Jun; 156(6):981-982. PMID: 25894240.
    Citations:    Fields:    Translation:Humans
  67. Katz JA, Swerdloff MA, Brass SD, Argoff CE, Markman J, Backonja M, Katz N. Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology. Neurology. 2015 Apr 07; 84(14):1503-4. PMID: 25846999.
    Citations: 4     Fields:    Translation:HumansAnimals
  68. Katz NP, Paillard FC, Edwards RR. Review of the performance of quantitative sensory testing methods to detect hyperalgesia in chronic pain patients on long-term opioids. Anesthesiology. 2015 Mar; 122(3):677-85. PMID: 25437498.
    Citations: 9     Fields:    Translation:Humans
  69. Wawrzyniak KM, Sabo A, McDonald A, Trudeau JJ, Poulose M, Brown M, Katz NP. Root cause analysis of prescription opioid overdoses. J Opioid Manag. 2015 Mar-Apr; 11(2):127-37. PMID: 25901478.
    Citations: 6     Fields:    Translation:Humans
  70. Smith SM, Paillard F, McKeown A, Burke LB, Edwards RR, Katz NP, Papadopoulos EJ, Rappaport BA, Slagle A, Strain EC, Wasan AD, Turk DC, Dworkin RH. Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review. J Pain. 2015 May; 16(5):389-411. PMID: 25660826; PMCID: PMC5460153.
    Citations: 9     Fields:    Translation:Humans
  71. Katz NP, Paillard FC, Ekman E. Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. J Orthop Surg Res. 2015 Feb 03; 10:24. PMID: 25645576; PMCID: PMC4327973.
    Citations: 89     Fields:    Translation:Humans
  72. Narayana A, Katz N, Shillington AC, Stephenson JJ, Harshaw Q, Frye CB, Portenoy RK. National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomes. Pain. 2015 Feb; 156(2):252-259. PMID: 25599446.
    Citations: 16     Fields:    Translation:Humans
  73. Dworkin RH, Turk DC, Trudeau JJ, Benson C, Biondi DM, Katz NP, Kim M. Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain. J Pain. 2015 Apr; 16(4):357-66. PMID: 25640290.
    Citations: 37     Fields:    Translation:Humans
  74. Osgood E, Trudeau JJ, Eaton TA, Jensen MP, Gammaitoni A, Simon LS, Katz N. Development of a bedside pain assessment kit for the classification of patients with osteoarthritis. Rheumatol Int. 2015 Jun; 35(6):1005-13. PMID: 25510290.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  75. McKeown A, Gewandter JS, McDermott MP, Pawlowski JR, Poli JJ, Rothstein D, Farrar JT, Gilron I, Katz NP, Lin AH, Rappaport BA, Rowbotham MC, Turk DC, Dworkin RH, Smith SM. Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review. J Pain. 2015 Mar; 16(3):199-206.e1-7. PMID: 25481494.
    Citations: 7     Fields:    Translation:Humans
  76. Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Hochberg MC, Jordan JM, Katz NP, Lin AH, Neogi T, Rappaport BA, Simon LS, Strand V. Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain. Arthritis Rheumatol. 2014 Dec; 66(12):3327-36. PMID: 25186636.
    Citations: 6     Fields:    Translation:Humans
  77. Gewandter JS, McDermott MP, McKeown A, Smith SM, Pawlowski JR, Poli JJ, Rothstein D, Williams MR, Bujanover S, Farrar JT, Gilron I, Katz NP, Rowbotham MC, Turk DC, Dworkin RH. Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 2014 Dec; 155(12):2714-2719. PMID: 25284072.
    Citations: 5     Fields:    Translation:Humans
  78. Katz N, Paillard FC, Van Inwegen R. A review of the use of the number needed to treat to evaluate the efficacy of analgesics. J Pain. 2015 Feb; 16(2):116-23. PMID: 25419989.
    Citations: 11     Fields:    Translation:Humans
  79. Hunsinger M, Smith SM, Rothstein D, McKeown A, Parkhurst M, Hertz S, Katz NP, Lin AH, McDermott MP, Rappaport BA, Turk DC, Dworkin RH. Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review. Pain. 2014 Nov; 155(11):2253-62. PMID: 25123543.
    Citations: 11     Fields:    Translation:Humans
  80. Gewandter JS, Dworkin RH, Turk DC, McDermott MP, Baron R, Gastonguay MR, Gilron I, Katz NP, Mehta C, Raja SN, Senn S, Taylor C, Cowan P, Desjardins P, Dimitrova R, Dionne R, Farrar JT, Hewitt DJ, Iyengar S, Jay GW, Kalso E, Kerns RD, Leff R, Leong M, Petersen KL, Ravina BM, Rauschkolb C, Rice ASC, Rowbotham MC, Sampaio C, Sindrup SH, Stauffer JW, Steigerwald I, Stewart J, Tobias J, Treede RD, Wallace M, White RE. Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. Pain. 2014 Sep; 155(9):1683-1695. PMID: 24865794.
    Citations: 31     Fields:    Translation:Humans
  81. Farrar JT, Troxel AB, Haynes K, Gilron I, Kerns RD, Katz NP, Rappaport BA, Rowbotham MC, Tierney AM, Turk DC, Dworkin RH. Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION study. Pain. 2014 Aug; 155(8):1622-1631. PMID: 24831421.
    Citations: 35     Fields:    Translation:Humans
  82. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Clin J Pain. 2014 Apr; 30(4):286-94. PMID: 23765045.
    Citations: 22     Fields:    Translation:Humans
  83. Trudeau J, Van Inwegen R, Eaton T, Bhat G, Paillard F, Ng D, Tan K, Katz NP. Assessment of pain and activity using an electronic pain diary and actigraphy device in a randomized, placebo-controlled crossover trial of celecoxib in osteoarthritis of the knee. Pain Pract. 2015 Mar; 15(3):247-55. PMID: 24494935.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  84. Gewandter JS, Smith SM, McKeown A, Burke LB, Hertz SH, Hunsinger M, Katz NP, Lin AH, McDermott MP, Rappaport BA, Williams MR, Turk DC, Dworkin RH. Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 2014 Mar; 155(3):461-466. PMID: 24275257.
    Citations: 11     Fields:    Translation:Humans
  85. O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O'Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox DJ, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain. 2013 Nov; 154(11):2324-2334. PMID: 24148704.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  86. Smith SM, Wang AT, Pereira A, Chang DR, McKeown A, Greene K, Rowbotham MC, Burke LB, Coplan P, Gilron I, Hertz SH, Katz NP, Lin AH, McDermott MP, Papadopoulos EJ, Rappaport BA, Sweeney M, Turk DC, Dworkin RH. Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations. Pain. 2013 Dec; 154(12):2769-2774. PMID: 23962590.
    Citations: 11     Fields:    Translation:Humans
  87. Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot A, Edwards RR, Haddox DJ, Jaffe JH, Jones CM, Kleber HD, Kopecky EA, Markman JD, Montoya ID, O'Brien C, Roland CL, Stanton M, Strain EC, Vorsanger G, Wasan AD, Weiss RD, Turk DC, Dworkin RH. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013 Nov; 154(11):2287-2296. PMID: 23792283.
    Citations: 64     Fields:    Translation:Humans
  88. Sanga P, Katz N, Polverejan E, Wang S, Kelly KM, Haeussler J, Thipphawong J. Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain. Pain. 2013 Oct; 154(10):1910-1919. PMID: 23748114.
    Citations: 40     Fields:    Translation:Humans
  89. Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Farrar JT, Katz NP, Lin AH, Rappaport BA, Rowbotham MC. Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis. Neurology. 2013 Jul 02; 81(1):67-75. PMID: 23700332; PMCID: PMC3770199.
    Citations: 14     Fields:    Translation:Humans
  90. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. Pain. 2013 Sep; 154(9):1632-1639. PMID: 23707278.
    Citations: 32     Fields:    Translation:Humans
  91. Katz NP, Birnbaum H, Brennan MJ, Freedman JD, Gilmore GP, Jay D, Kenna GA, Madras BK, McElhaney L, Weiss RD, White AG. Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care. 2013 Apr; 19(4):295-302. PMID: 23725361; PMCID: PMC3680126.
    Citations: 18     Fields:    Translation:HumansPHPublic Health
  92. Smith SM, Wang AT, Katz NP, McDermott MP, Burke LB, Coplan P, Gilron I, Hertz SH, Lin AH, Rappaport BA, Rowbotham MC, Sampaio C, Sweeney M, Turk DC, Dworkin RH. Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 2013 Jul; 154(7):997-1008. PMID: 23602344.
    Citations: 22     Fields:    
  93. Comer SD, Zacny JP, Dworkin RH, Turk DC, Bigelow GE, Foltin RW, Jasinski DR, Sellers EM, Adams EH, Balster R, Burke LB, Cerny I, Colucci RD, Cone E, Cowan P, Farrar JT, Haddox DJ, Haythornthwaite JA, Hertz S, Jay GW, Johanson CE, Junor R, Katz NP, Klein M, Kopecky EA, Leiderman DB, McDermott MP, O'Brien C, O'Connor AB, Palmer PP, Raja SN, Rappaport BA, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Sokolowska M, Stauffer JW, Walsh SL. Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations. Pain. 2012 Dec; 153(12):2315-2324. PMID: 22998781; PMCID: PMC3494795.
    Citations: 26     Fields:    Translation:Humans
  94. Smith SM, Chang DR, Pereira A, Shah N, Gilron I, Katz NP, Lin AH, McDermott MP, Rappaport BA, Rowbotham MC, Sampaio C, Turk DC, Dworkin RH. Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review. Pain. 2012 Dec; 153(12):2415-2421. PMID: 22985899.
    Citations: 18     Fields:    Translation:Humans
  95. Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, Zacny JP, Ahdieh H, Burke LB, Cowan P, Jacobs P, Malamut R, Markman J, Michna E, Palmer P, Peirce-Sandner S, Potter JS, Raja SN, Rauschkolb C, Roland CL, Webster LR, Weiss RD, Wolf K. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain. 2012 Oct; 153(10):1997-2008. PMID: 22770841.
    Citations: 17     Fields:    Translation:Humans
  96. Katz NP. The measurement of symptoms and side effects in clinical trials of chronic pain. Contemp Clin Trials. 2012 Sep; 33(5):903-11. PMID: 22561389.
    Citations: 6     Fields:    Translation:Humans
  97. Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice ASC, Sampaio C, Skljarevski V, Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain. 2012 Jun; 153(6):1148-1158. PMID: 22494920.
    Citations: 76     Fields:    Translation:Humans
  98. Cruciani RA, Katz N, Portenoy RK. Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity. J Pain. 2012 Apr; 13(4):379-89. PMID: 22424912.
    Citations: 2     Fields:    Translation:Humans
  99. Osgood ED, Eaton TA, Trudeau JJ, Katz NP. A brief survey to characterize oxycodone abuse patterns in adolescents enrolled in two substance abuse recovery high schools. Am J Drug Alcohol Abuse. 2012 Mar; 38(2):166-70. PMID: 22220502.
    Citations: 8     Fields:    Translation:Humans
  100. Brown J, Setnik B, Lee K, Wase L, Roland CL, Cleveland JM, Siegel S, Katz N. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag. 2011 Nov-Dec; 7(6):467-83. PMID: 22320029.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  101. Eaton TA, Comer SD, Revicki DA, Trudeau JJ, van Inwegen RG, Stauffer JW, Katz NP. Determining the clinically important difference in visual analog scale scores in abuse liability studies evaluating novel opioid formulations. Qual Life Res. 2012 Aug; 21(6):975-81. PMID: 21964915; PMCID: PMC3628592.
    Citations: 6     Fields:    Translation:Humans
  102. Denisco RC, Kenna GA, O'Neil MG, Kulich RJ, Moore PA, Kane WT, Mehta NR, Hersh EV, Katz NP. Prevention of prescription opioid abuse: the role of the dentist. J Am Dent Assoc. 2011 Jul; 142(7):800-10. PMID: 21719802.
    Citations: 33     Fields:    Translation:HumansPHPublic Health
  103. Katz N, Borenstein DG, Birbara C, Bramson C, Nemeth MA, Smith MD, Brown MT. Efficacy and safety of tanezumab in the treatment of chronic low back pain. Pain. 2011 Oct; 152(10):2248-2258. PMID: 21696889.
    Citations: 83     Fields:    Translation:Humans
  104. Benneyan JC, Villapiano A, Katz N, Duffy M, Budman SH, Butler SF. Illustration of a statistical process control approach to regional prescription opioid abuse surveillance. J Addict Med. 2011 Jun; 5(2):99-109. PMID: 21769055.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  105. Katz N, Dart RC, Bailey E, Trudeau J, Osgood E, Paillard F. Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse. 2011 Jul; 37(4):205-17. PMID: 21517709.
    Citations: 48     Fields:    Translation:Humans
  106. Hersh EV, Kane WT, O'Neil MG, Kenna GA, Katz NP, Golubic S, Moore PA. Prescribing recommendations for the treatment of acute pain in dentistry. Compend Contin Educ Dent. 2011 Apr; 32(3):22, 24-30; quiz 31-2. PMID: 21560740.
    Citations: 12     Fields:    Translation:Humans
  107. Dworkin RH, Turk DC, Katz NP, Rowbotham MC, Peirce-Sandner S, Cerny I, Clingman CS, Eloff BC, Farrar JT, Kamp C, McDermott MP, Rappaport BA, Sanhai WR. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION. Pain. 2011 Mar; 152(3 Suppl):S107-S115. PMID: 21145657.
    Citations: 26     Fields:    Translation:Humans
  108. Bombardier C, Evans CJ, Katz N, Mardekian J, Zlateva G, Simon LS. Further qualification of a therapeutic responder index for patients with chronic low back pain. J Rheumatol. 2011 Feb; 38(2):362-9. PMID: 21041275.
    Citations: 7     Fields:    Translation:Humans
  109. Katz N, Hale M, Morris D, Stauffer J. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain. Postgrad Med. 2010 Jul; 122(4):112-28. PMID: 20675975.
    Citations: 10     Fields:    Translation:Humans
  110. Katz NP, Birnbaum HG, Castor A. Volume of prescription opioids used nonmedically in the United States. J Pain Palliat Care Pharmacother. 2010 Jun; 24(2):141-4. PMID: 20504136.
    Citations: 10     Fields:    Translation:Humans
  111. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliomäki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve BB, Rhodes T, Sampaio C, Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010 May; 149(2):177-193. PMID: 20207481.
    Citations: 122     Fields:    Translation:Humans
  112. Dworkin RH, Turk DC, Peirce-Sandner S, McDermott MP, Farrar JT, Hertz S, Katz NP, Raja SN, Rappaport BA. Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database. Pain. 2010 Jul; 150(1):12-16. PMID: 20202753.
    Citations: 10     Fields:    Translation:Humans
  113. Katz N, Panas L, Kim M, Audet AD, Bilansky A, Eadie J, Kreiner P, Paillard FC, Thomas C, Carrow G. Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf. 2010 Feb; 19(2):115-23. PMID: 20014166.
    Citations: 53     Fields:    Translation:Humans
  114. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009 Dec; 15(12):897-906. PMID: 20001171.
    Citations: 76     Fields:    Translation:Humans
  115. Katz N, Sun S, Johnson F, Stauffer J. ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety. J Pain. 2010 Apr; 11(4):303-11. PMID: 19944650.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  116. Butler SF, Fernandez KC, Chang A, Benoit C, Morey LC, Black R, Katz N. Measuring attractiveness for abuse of prescription opioids. Pain Med. 2010 Jan; 11(1):67-80. PMID: 20002325.
    Citations: 19     Fields:    Translation:Humans
  117. Butler SF, Black R, Grimes Serrano JM, Folensbee L, Chang A, Katz N. Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulation. Pain Med. 2010 Jan; 11(1):81-91. PMID: 20002324.
    Citations: 6     Fields:    Translation:Humans
  118. Katz N. Enriched enrollment randomized withdrawal trial designs of analgesics: focus on methodology. Clin J Pain. 2009 Nov-Dec; 25(9):797-807. PMID: 19851161.
    Citations: 24     Fields:    Translation:Humans
  119. Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain. 2009 Feb; 25(2):170-5. PMID: 19333165.
    Citations: 70     Fields:    Translation:HumansAnimals
  120. White AG, Birnbaum HG, Rothman DB, Katz N. Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction. Appl Health Econ Health Policy. 2009; 7(1):61-70. PMID: 19558195.
    Citations: 12     Fields:    Translation:Humans
  121. Butler SF, Budman SH, Licari A, Cassidy TA, Lioy K, Dickinson J, Brownstein JS, Benneyan JC, Green TC, Katz N. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiol Drug Saf. 2008 Dec; 17(12):1142-54. PMID: 18932173.
    Citations: 35     Fields:    Translation:Humans
  122. Stowell CP, Trieu MQ, Chuang H, Katz N, Quarrington C. Ultrasound-enabled topical anesthesia for pain reduction of phlebotomy for whole blood donation. Transfusion. 2009 Jan; 49(1):146-53. PMID: 18954400.
    Citations: 4     Fields:    Translation:Humans
  123. Bieber CM, Fernandez K, Borsook D, Brennan MJ, Butler SF, Jamison RN, Osgood E, Sharpe-Potter J, Thomson HN, Weiss RD, Katz NP. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Exp Clin Psychopharmacol. 2008 Oct; 16(5):429-34. PMID: 18837639.
    Citations: 11     Fields:    Translation:Humans
  124. Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain. 2008 Oct 31; 139(3):485-493. PMID: 18706763.
    Citations: 63     Fields:    Translation:Humans
  125. Katz N, Fernandez K, Chang A, Benoit C, Butler SF. Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain. 2008 Jul-Aug; 24(6):528-35. PMID: 18574362.
    Citations: 26     Fields:    Translation:Humans
  126. Katz N, Houle B, Fernandez KC, Kreiner P, Thomas CP, Kim M, Carrow GM, Audet A, Brushwood D. Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. Pain Med. 2008 Jul-Aug; 9(5):587-94. PMID: 18565002.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  127. Spierings EL, Brevard JA, Katz NP. Two-minute skin anesthesia through ultrasound pretreatment and iontophoretic delivery of a topical anesthetic: a feasibility study. Pain Med. 2008 Jan-Feb; 9(1):55-9. PMID: 18254767.
    Citations: 8     Fields:    Translation:Humans
  128. Katz N. Abuse-deterrent opioid formulations: are they a pipe dream? Curr Rheumatol Rep. 2008 Jan; 10(1):11-8. PMID: 18457606.
    Citations: 23     Fields:    Translation:Humans
  129. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008 Feb; 9(2):105-21. PMID: 18055266.
    Citations: 1010     Fields:    Translation:Humans
  130. Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C, Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007 Oct; 23(8):648-60. PMID: 17885342.
    Citations: 43     Fields:    Translation:HumansAnimalsPHPublic Health
  131. Butler SF, Venuti SW, Benoit C, Beaulaurier RL, Houle B, Katz N. Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postings. Clin J Pain. 2007 Sep; 23(7):619-28. PMID: 17710013.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  132. Simon LS, Evans C, Katz N, Bombardier C, West C, Robbins J, Copley-Merriman C, Markman J, Coombs JH. Preliminary development of a responder index for chronic low back pain. J Rheumatol. 2007 Jun; 34(6):1386-91. PMID: 17552065.
    Citations: 6     Fields:    Translation:Humans
  133. Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, Jamison RN. Development and validation of the Current Opioid Misuse Measure. Pain. 2007 Jul; 130(1-2):144-56. PMID: 17493754; PMCID: PMC1950245.
    Citations: 203     Fields:    Translation:Humans
  134. Katz N. Opioids: after thousands of years, still getting to know you. Clin J Pain. 2007 May; 23(4):303-6. PMID: 17449990.
    Citations: 7     Fields:    Translation:HumansAnimals
  135. Katz NP, Adams EH, Benneyan JC, Birnbaum HG, Budman SH, Buzzeo RW, Carr DB, Cicero TJ, Gourlay D, Inciardi JA, Joranson DE, Kesslick J, Lande SD. Foundations of opioid risk management. Clin J Pain. 2007 Feb; 23(2):103-18. PMID: 17237659.
    Citations: 33     Fields:    Translation:Humans
  136. Katz N, Rauck R, Ahdieh H, Ma T, Gerritsen van der Hoop R, Kerwin R, Podolsky G. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin. 2007 Jan; 23(1):117-28. PMID: 17257473.
    Citations: 29     Fields:    Translation:Humans
  137. Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, Schein JR, Katz NP. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Clin J Pain. 2006 Oct; 22(8):667-76. PMID: 16988561.
    Citations: 45     Fields:    Translation:Humans
  138. Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006 Sep; 32(3):287-93. PMID: 16939853.
    Citations: 42     Fields:    Translation:HumansCTClinical Trials
  139. Butler SF, Benoit C, Budman SH, Fernandez KC, McCormick C, Venuti SW, Katz N. Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J. 2006 Feb 02; 3:5. PMID: 16457713; PMCID: PMC1382206.
    Citations: 14     Fields:    
  140. Katz N. Methodological issues in clinical trials of opioids for chronic pain. Neurology. 2005 Dec 29; 65(12 Suppl 4):S32-49. PMID: 16385103.
    Citations: 17     Fields:    Translation:Humans
  141. Passik SD, Kirsh KL, Whitcomb L, Schein JR, Kaplan MA, Dodd SL, Kleinman L, Katz NP, Portenoy RK. Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool. J Opioid Manag. 2005 Nov-Dec; 1(5):257-66. PMID: 17319559.
    Citations: 10     Fields:    Translation:Humans
  142. White AG, Birnbaum HG, Mareva MN, Daher M, Vallow S, Schein J, Katz N. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005 Jul-Aug; 11(6):469-79. PMID: 15998164.
    Citations: 52     Fields:    Translation:HumansCTClinical Trials
  143. Katz N, Benoit C. Opioids for neuropathic pain. Curr Pain Headache Rep. 2005 Jun; 9(3):153-60. PMID: 15907252.
    Citations: 7     Fields:    Translation:Humans
  144. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005 Jan; 113(1-2):9-19. PMID: 15621359.
    Citations: 1115     Fields:    
  145. Battisti WP, Katz NP, Weaver AL, Matsumoto AK, Kivitz AJ, Polis AB, Geba GP. Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials. J Pain. 2004 Nov; 5(9):511-20. PMID: 15556830.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  146. Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage. 2004 Oct; 28(4):396-411. PMID: 15471658.
    Citations: 24     Fields:    Translation:Humans
  147. Reynolds L, Rauck R, Webster L, DuPen S, Heinze E, Portenoy R, Katz N, Charapata S, Wallace M, Fisher DM. Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain. Pain. 2004 Jul; 110(1-2):182-8. PMID: 15275766.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  148. Katz N, Rodgers DB, Krupa D, Reicin A. Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trials. Curr Med Res Opin. 2004 May; 20(5):651-8. PMID: 15140330.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  149. Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, Dodd SL, Schein JR. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004 Apr; 26(4):552-61. PMID: 15189752.
    Citations: 41     Fields:    Translation:Humans
  150. Katz NP, Shapiro DE, Herrmann TE, Kost J, Custer LM. Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device. Anesth Analg. 2004 Feb; 98(2):371-376. PMID: 14742372.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  151. Katz N. Reporting of clinical trials of analgesia. J Thorac Cardiovasc Surg. 2004 Feb; 127(2):605; author reply 606. PMID: 14762388.
    Citations:    Fields:    Translation:Humans
  152. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003 Dec; 106(3):337-345. PMID: 14659516.
    Citations: 346     Fields:    Translation:Humans
  153. Katz NP, Sherburne S, Beach M, Rose RJ, Vielguth J, Bradley J, Fanciullo GJ. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003 Oct; 97(4):1097-1102. PMID: 14500164.
    Citations: 57     Fields:    Translation:HumansPHPublic Health
  154. Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage. 2003 Oct; 26(4):913-21. PMID: 14527760.
    Citations: 27     Fields:    Translation:Humans
  155. Rosman NP, Adhami S, Mannheim GB, Katz NP, Klucznik RP, Muriello MA. Basilar artery occlusion in children: misleading presentations, "locked-in" state, and diagnostic importance of accompanying vertebral artery occlusion. J Child Neurol. 2003 Jul; 18(7):450-62. PMID: 12940650.
    Citations: 10     Fields:    Translation:Humans
  156. Katz N, Ju WD, Krupa DA, Sperling RS, Bozalis Rodgers D, Gertz BJ, Gimbel J, Coleman S, Fisher C, Nabizadeh S, Borenstein D. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine (Phila Pa 1976). 2003 May 01; 28(9):851-8; discussion 859. PMID: 12941996.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  157. Katz N. Coxibs: Evolving role in pain management. Semin Arthritis Rheum. 2002 Dec; 32(3 Suppl 1):15-24. PMID: 12528070.
    Citations: 1     Fields:    Translation:Humans
  158. Katz NP, Gammaitoni AR, Davis MW, Dworkin RH. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Pain Med. 2002 Dec; 3(4):324-32. PMID: 15099237.
    Citations: 18     Fields:    
  159. Jamison RN, Gracely RH, Raymond SA, Levine JG, Marino B, Herrmann TJ, Daly M, Fram D, Katz NP. Comparative study of electronic vs. paper VAS ratings: a randomized, crossover trial using healthy volunteers. Pain. 2002 Sep; 99(1-2):341-7. PMID: 12237213.
    Citations: 47     Fields:    Translation:HumansCTClinical Trials
  160. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002 Jul-Aug; 18(4 Suppl):S76-82. PMID: 12479257.
    Citations: 32     Fields:    Translation:Humans
  161. Katz N. The impact of pain management on quality of life. J Pain Symptom Manage. 2002 Jul; 24(1 Suppl):S38-47. PMID: 12204486.
    Citations: 55     Fields:    Translation:Humans
  162. Jamison RN, Raymond SA, Levine JG, Slawsby EA, Nedeljkovic SS, Katz NP. Electronic diaries for monitoring chronic pain: 1-year validation study. Pain. 2001 Apr; 91(3):277-285. PMID: 11275385.
    Citations: 58     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Katz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (399)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.